BSECompany Update15 Oct 2026 · 15 Oct 2026, 11:29 am

Certificate under Reg. 74(5)of SEBI (DP)30.09.2026

Kobo Biotech Ltd-$ · 531541

✦ AI SummaryRegulatory

Kobo Biotech Ltd has submitted a certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, confirming compliance for the quarter ended 30th September, 2026.

Analysis Scores

Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Kobo Biotech Ltd-$ - 531541 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Attachments (1)

📄

e4c2463c-8d9d-4767-b0d4-6ac472f4b447.pdf

pdf

Download →
View document text
KOBO BIOTECH LIMITED Corp. Office: Unit 104, Hyde Park, Saki Vihar Road, Opp. Ansa Industrial Estate, Andheri (E), Mumbai - 400 072 Tel.: +91-22 4287 1210 • Fax: +91-22-4287 1285 E-mail: info@kobobiotech.com • Website: www.kobobiotech.com (CIN : L24110TG1993PLC16112) 5th October, 2026 BSE LIMITED P J Towers Dalal Street, Fort, Mumbai 400 001 Scrip Code : 531541 Dear Sir/Madam, Sub: Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30th September, 2026 We are enclosing herewith Certificate issued by XL Softech Systems Ltd., Registrar and Share Transfer Agent (RTA) of the Company confirming compliance under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30th September, 2026. Kindly take the same on your record and acknowledge. Thanking you, For KOBO BIOTECH LIMITED Namrata Randeri Erstwhile Insolvent Professional & Chairman of Management Committee IBBI Registration No. IBBI/IPA- 001/IP-P01585/2019-20/12495 Registered office: Plot No. 121A/ 1, Western Hills, Addagutta Society, Opp. JNTU, Kukatpally, Hyderabad, Telangana, 500072 Date: 03.10.2026 The Company Secretary, KOBO BIOTECH LIMITED Subject: Confirmation Certificate in the matter of Regulation 74(5) of Securities and Exchange Board of india (Depositories and Participants) Regulations, 2018. Reference: NSDL/CIR/II/5/2019 dated 25th January, 2019. CDSL/OPS/RTA/POLCY/2019/14 dated 25th January, 2019. SEBI vide its letter ref no. MRD/DOP2/DSA2/OW/2019/2498/1 dated 24th January, 2019 Dear Sir/Madam, In reference to the above captioned regulation, We hereby confirm that the securities received from the depository participants for dematerialization during the quarter ended 30th September, 2026 were confirmed (accepted/rejected) to the depositories by us and that securities comprised in the said certificates have been listed on the stock exchange where the earlier issued securities are listed. We hereby also confirm that the security certificates received for dematerialization have been mutilated and cancelled after due verification by the depository participant and the name of the depositories have been substituted in register of members as the registered owner within 30 days. We request you to kindly take note of the above in your records. Thanking You, Yours faithfully, For XL Softech Systems Limited Authorised Signatory